Want to take quizzes and track your credits?
Ipsilateral axillary lymphadenopathy (IAL) after COVID-19 vaccination results in diagnostic conundrums.1- 3 Expert guidelines advise IAL management based on patient symptoms, imaging results, and risk factors.2,4,5 We report on the frequency and outcomes of breast imaging–identified IAL after recent COVID-19 vaccination.
Sign in to take quiz and track your certificates
CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.
Accepted for Publication: April 22, 2022.
Published: June 8, 2022. doi:10.1001/jamanetworkopen.2022.16172
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2022 Zhou W et al. JAMA Network Open.
Corresponding Author: Wenhui Zhou, MD, PhD, Department of Radiology, Stanford University Medical Center, 300 Pasteur Dr, H1330, MC: 5621, Stanford, CA 94305 (firstname.lastname@example.org).
Author Contributions: Dr Zhou had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: All authors.
Acquisition, analysis, or interpretation of data: Zhou, DeMartini.
Drafting of the manuscript: Zhou, DeMartini.
Critical revision of the manuscript for important intellectual content: Zhou, Ikeda.
Statistical analysis: Zhou.
Administrative, technical, or material support: Zhou, Ikeda.
Conflict of Interest Disclosures: Dr DeMartini reported receiving personal fees from Kheiron Medical Technologies and grants from Whiterabbit.ai outside the submitted work. Dr Ikeda reported serving as a consultant for Hologic Inc, holding stock in Moderna and Pfizer, and serving as a lecturer for postgraduate CME radiology courses for CME Science outside the submitted work. No other disclosures were reported.
You currently have no searches saved.
You currently have no courses saved.